Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

BIOMUNE SAS : revenue, balance sheet and financial ratios

BIOMUNE SAS is a French company founded 5 years ago, specialized in the sector Commerce de gros (commerce interentreprises) de produits pharmaceutiques. Based in SAINT-GENIS-LAVAL (69230), this company of category PME has financial data available below. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-02

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - BIOMUNE SAS (SIREN 893388397)
Indicator 2022
Revenue N/C
Net income 0 €
EBITDA N/C
Net margin N/C

Revenue and income statement

In 2022, BIOMUNE SAS records a net loss of 0 €. This deficit will reduce equity on the balance sheet.

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 0%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 100%. This high autonomy means the company finances most of its assets through equity, a sign of strength.

Debt ratio (2022) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

0.0%

Financial autonomy (2022) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

100.0%

Solvency indicators evolution
BIOMUNE SAS

Sector positioning

Debt ratio
0.0 2022
2022
Q1: 0.0
Med: 6.23
Q3: 53.97
Excellent

In 2022, the debt ratio of BIOMUNE SAS (0.00) ranks in the bottom 25% of the sector, which is positive. This ratio measures the weight of debt relative to equity. A low ratio indicates a solid financial structure with little dependence on creditors.

Financial autonomy
100.0% 2022
2022
Q1: 15.33%
Med: 37.18%
Q3: 59.34%
Excellent

In 2022, the financial autonomy of BIOMUNE SAS (100.0%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.

Positioning of BIOMUNE SAS in its sector

Comparison with sector Commerce de gros (commerce interentreprises) de produits pharmaceutiques

Similar companies (Commerce de gros (commerce interentreprises) de produits pharmaceutiques)

Compare BIOMUNE SAS with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de gros (commerce interentreprises) de produits pharmaceutiques

Frequently asked questions about BIOMUNE SAS

What is the revenue of BIOMUNE SAS ?

The revenue of BIOMUNE SAS is not publicly disclosed (confidential accounts filed with INPI).

Is BIOMUNE SAS profitable?

Profitability information is not publicly available.

Where is the headquarters of BIOMUNE SAS ?

The headquarters of BIOMUNE SAS is located in SAINT-GENIS-LAVAL (69230), in the department Rhone.

Where to find the tax return of BIOMUNE SAS ?

The tax return of BIOMUNE SAS is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does BIOMUNE SAS operate?

BIOMUNE SAS operates in the sector Commerce de gros (commerce interentreprises) de produits pharmaceutiques (NAF code 46.46Z). See the 'Sector positioning' section above to compare the company with its competitors.